Virtus Investment Partners, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US92828Q1094
USD
159.06
3.49 (2.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Virtus Investment Partners, Inc. stock-summary
stock-summary
Virtus Investment Partners, Inc.
Capital Markets
Virtus Investment Partners, Inc. (Virtus) is a provider of investment management and related services to individuals and institutions. The Company provides its products in various forms and through multiple distribution channels. Its retail products include open-end mutual funds, closed-end funds, exchange traded funds, variable insurance funds, undertakings for collective investments in transferable securities (UCITS) and separately managed accounts. Its open-end mutual funds are distributed through intermediaries. Its closed-end funds trade on the New York Stock Exchange. Its variable insurance funds are available as investment options in variable annuities and life insurance products distributed by life insurance companies. Separately managed accounts consists of intermediary programs, sponsored and distributed by unaffiliated brokerage firms, and private client accounts, which are offered to the high net-worth clients of its affiliated managers.
Company Coordinates stock-summary
Company Details
ONE FINANCIAL PLAZA, 26TH FLOOR , HARTFORD CT : 06103
stock-summary
Tel: 1 860 2634707
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 66 Schemes (46.73%)

Foreign Institutions

Held by 112 Foreign Institutions (7.39%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Mark Treanor
Non-Executive Independent Chairman of the Board
Mr. George Aylward
President, Chief Executive Officer, Director
Mr. Peter Bain
Independent Director
Dr. Susan Fleming
Independent Director
Mr. Paul Greig
Independent Director
Mr. Timothy Holt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
209 Million
(Quarterly Results - Jun 2025)
Net Profit:
43 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 2,180 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.75%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

15.74%

stock-summary
Price to Book

2.43